Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

334.50p
   
  • Change Today:
      6.00p
  • 52 Week High: 470.00
  • 52 Week Low: 166.80
  • Currency: UK Pounds
  • Shares Issued: 100.00m
  • Volume: 185,854
  • Market Cap: £334.50m
  • RiskGrade: 125

Financial Analysis

Select chart: EPS | Dividend | Revenue

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 64.06 (20.89) (22.10)p n/a n/a n/a n/a 0.0%
31-Dec-20 87.73 (6.57) (7.81)p n/a n/a n/a n/a 0.0%
31-Dec-21 142.80 19.88 22.77p 54.0 n/a n/a n/a 0.0%
31-Dec-22 139.99 (45.98) (41.29)p n/a n/a n/a n/a 0.0%
31-Dec-23 89.54 (188.53) (163.11)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 129.32 (39.39) (40.05)p n/a n/a n/a n/a 0.0%
31-Dec-25 164.41 (23.17) (25.40)p n/a n/a n/a n/a 0.0%
31-Dec-26 205.12 5.05 (6.91)p n/a n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 54.02 n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

OXB Market Data

Currency UK Pounds
Share Price 334.50p
Change Today 6.00p
% Change 1.83 %
52 Week High 470.00
52 Week Low 166.80
Volume 185,854
Shares Issued 100.00m
Market Cap £334.50m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
27.51% below the market average27.51% below the market average27.51% below the market average27.51% below the market average27.51% below the market average
25.49% above the sector average25.49% above the sector average25.49% above the sector average25.49% above the sector average25.49% above the sector average
Price Trend
3.07% above the market average3.07% above the market average3.07% above the market average3.07% above the market average3.07% above the market average
47.17% above the sector average47.17% above the sector average47.17% above the sector average47.17% above the sector average47.17% above the sector average
Income Not Available
Growth
52.14% below the market average52.14% below the market average52.14% below the market average52.14% below the market average52.14% below the market average
58.82% below the sector average58.82% below the sector average58.82% below the sector average58.82% below the sector average58.82% below the sector average

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 5
Sell 0
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 23-May-2024

Time Volume / Share Price
16:35 20,342 @ 334.50p
16:35 123 @ 334.50p
16:35 72 @ 334.50p
16:35 116 @ 334.50p
16:35 28 @ 334.50p

OXB Key Personnel

CFO Stuart Paynter
CEO Frank Mathias

Top of Page